Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization

The COVID-19 pandemic continues to wreak havoc as worldwide SARS-CoV-2 infection, hospitalization, and death rates climb unabated. Effective vaccines remain the most promising approach to counter SARS-CoV-2. Yet, while promising results are emerging from COVID-19 vaccine trials, the need for multipl...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiba, Shiho, Frey, Steven J., Halfmann, Peter J., Kuroda, Makoto, Maemura, Tadashi, Yang, Jie E., Wright, Elizabeth R., Kawaoka, Yoshihiro, Kane, Ravi S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134492/
https://www.ncbi.nlm.nih.gov/pubmed/34011948
http://dx.doi.org/10.1038/s42003-021-02128-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134492/
https://www.ncbi.nlm.nih.gov/pubmed/34011948
http://dx.doi.org/10.1038/s42003-021-02128-8

Ejemplares similares